Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (49)Enhertu approved in US for 1L HER2+ metastatic BC
Preheader (150)Enhertu plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic bre
Typography
Arial
Colors
Text Analysis
Body Words146
Subject Words9
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score0.8
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeEarly Morning

Enhertu approved in US for 1L HER2+ metastatic BC

Enhertu plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic bre
Enhertu approved in US for 1L HER2+ metastatic BC